Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ma, Yulong ^a   Guo, Hang ^a,b   Zhang, Lixia ^c   Tao, Liang ^a   Yin, Anqi ^a   Liu, Zhaoyu ^a   Li, Yan ^a   Dong, Hailong ^a   Xiong, Lize ^a   Hou, Wugang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL; APOPTOSIS; ASTROCYTE; BRAIN ISCHEMIA; DISEASE MODEL; DRUG EFFECTS; ESTROGEN THERAPY; FEMALE; HIPPOCAMPUS; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN ISCHEMIA; CASPASE 3; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; REPERFUSION INJURY;

EID: 84959017076     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21467     Document Type: Article

References (57)

1. Appelros, P., Stegmayr, B., Terent, A. Sex differences in stroke epidemiology: a systematic review. Stroke 40, 1082-1090 (2009).
2. Cai, M. et al. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice. Neurosci Lett. 558, 115-119 (2014).
3. Ma, Y. et al. The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusion. BMC Neurosci. 14, 118 (2013).
4. Scott, E., Zhang, Q., Wang, R., Vadlamudi, R., Brann, D. Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol. 33, 85-104 (2012).
5. Rossouw, J. E. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 288, 321-333 (2002).
6. Wassertheil-Smoller, S. et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 289, 2673-2684 (2003).
7. Arevalo, M. A., Santos-Galindo, M., Bellini, M. J., Azcoitia, I., Garcia-Segura, L. M. Actions of estrogens on glial cells: Implications for neuroprotection. Biochim Biophys Acta. 1800, 1106-1112 (2010).
8. Takano, T., Oberheim, N., Cotrina, M. L., Nedergaard, M. Astrocytes and ischemic injury. Stroke 40, S8-12 (2009).
9. Barreto, G., White, R. E., Ouyang, Y., Xu, L., Giffard, R. G. Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem. 11(2), 164-173 (2011).
10. Funakoshi, T., Yanai, A., Shinoda, K., Kawano, M. M., Mizukami, Y. G. protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun. 346, 904-910 (2006).
11. Hosli, E., Ruhl, W., Hosli, L. Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: colocalization with cholinergic receptors. Int J Dev Neurosci. 18, 101-111 (2000).
12. Garcia-Ovejero, D., Veiga S., Garcia-Segura, L. M., Doncarlos, L. L. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol. 450, 256-271 (2002).
13. Dhandapani, K. M., Brann, D. W. Role of astrocytes in estrogen-mediated neuroprotection. Exp Gerontol. 42, 70-75 (2007).
14. Spence, R. D. et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 108, 8867-8872 (2011).
15. Hirayama, Y. et al. Astrocyte-mediated ischemic tolerance. J Neurosci. 35, 3794-3805 (2015).
16. Azcoitia, I., Sierra, A., Garcia-Segura, L. M. Localization of estrogen receptor beta-immunoreactivity in astrocytes of the adult rat brain. Glia. 26, 260-267 (1999).
17. Mitra, S. W. et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology. 144, 2055-2067 (2003).
18. Rozovsky, I., Hoving, S., Anderson, C. P., O'Callaghan, J., Finch, C. E. Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. Neurosci Lett. 323, 191-194 (2002).
19. Stone, D. J., Song, Y., Anderson, C. P., Krohn, K. K., Finch, C. E., Rozovsky I. Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology. 139, 3202-3209 (1998).
20. Arimoto, J. M., Wong, A., Rozovsky, I., Lin, S. W., Morgan, T. E., Finch, C. E. Age increase of estrogen receptor-? (ER? ) in cortical astrocytes impairs neurotrophic support in male and femalerats. Endocrinology. 154, 2101-2013 (2013).
21. Rozovsky, I. et al. Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. Endocrinology. 143, 636-646 (2002).
22. Stauffer, S. R. et al. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem. 43, 4934-4947 (2000).
23. Meyers, M. J., Sun, J., Carlson, K. E., Marriner, G. A., Katzenellenbogen, B. S., Katzenellenbogen, J. A. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem. 44, 4230-4251 (2001).
24. Flugge, G., Araya-Callis, C., Garea-Rodriguez, E., Stadelmann-Nessler, C., Fuchs E. NDRG2 as a marker protein for brain astrocytes. Cell Tissue Res. 357, 31-41 (2014).
25. Ma, Y. et al. Estrogen regulates the expression of Ndrg2 in astrocytes. Brain Res. 1569, 1-8 (2014).
26. Ouyang, Y. B., Voloboueva, L. A., Xu, L. J., Giffard, R. G. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J Neurosci. 27, 4253-4260 (2007).
27. Jover, T. et al. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J Neurosci. 22, 2115-2124 (2002).
28. Miller, N. R., Jover, T., Cohen, H. W., Zukin, R. S., Etgen, A. M. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology. 146, 3070-3079 (2005).
29. Sharma, K., Mehra, R. D. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res. 1204, 1-15 (2008).
30. Benner, E. J. et al. Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4. Nature 497, 369-373 (2013).
31. Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., Wise, P. M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci. 19, 6385-6393 (1999).
32. Dubal, D. B. et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98, 1952-1957 (2001).
33. Spence, R. D. et al. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ER? signaling on astrocytes but not through ER? signaling on astrocytes or neurons. J Neurosci. 33, 10924-10933 (2013).
34. Guo, J., Duckles, S. P., Weiss, J. H., Li, X., Krause, D. N. 17?-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion. Free Radic Biol Med. 52, 2151-60 (2012).
35. Wang, L., Andersson, S., Warner, M., Gustafsson, J. A. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA 98, 2792-2796 (2001).
36. Carswell, H. V., Macrae, I. M., Gallagher, L., Harrop, E., Horsburgh, K. J. Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol. 287, H1501-H1504 (2004).
37. Cimarosti, H. et al. The effects of estradiol on estrogen receptor and glutamate transporter expression in organotypic hippocampal cultures exposed to oxygen-glucose deprivation. Neurochem Res. 31, 483-490 (2006).
38. Raval, A. P., Borges-Garcia, R., Javier Moreno, W., Perez-Pinzon, M. A., Bramlett, H. Periodic 17?-estradiol pretreatment protects rat brain from cerebral ischemic damage via estrogen receptor-? . PLoS One. 8, e60716 (2013).
39. Liu, F. et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 11, 334-343 (2008).
40. Zhao, L., Wu, T. W., Brinton, R. D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010, 22-34 (2004).
41. Chakrabarti, M. et al. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 109, 22-3 (2014).
42. Zhang, L. et al. Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabeticfemale mice. J Clin Invest. 113, 85-95 (2004).
43. Baker, A. E., Brautigam, V. M., Watters, J. J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 145, 5021-5032 (2004).
44. Wu, W. F. et al. Targeting estrogen receptor ? in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 110, 3543-3548 (2013).
45. Rodriguez-Perez, A. I., Borrajo, A., Valenzuela, R., Lanciego, J. L., Labandeira-Garcia, J. L. Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats. Neurobiol Aging. 36, 1194-1208 (2015).
46. Vegeto, E. et al. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 147, 2263-2272 (2006).
47. Lee, Y. et al. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci. 16, 1392-1400 (2013).
48. Farr, T. D., Carswell, H. V., Gsell, W., Macrae, I. M. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res. 1185, 275-282 (2007).
49. Ardelt, A. A. et al. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke 36, 337-341 (2005).
50. Lasota, A., Danowska-Klonowska, D. Experimental osteoporosis-different methods of ovariectomy in female white rats. Rocz Akad Med Bialymst. 49, 129-131 (2004).
51. McLean, A. C., Valenzuela, N., Fai, S., Bennett, S. A. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 15, e4389 (2012).
52. Kitagawa, K. et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 29, 2616-2621 (1998).
53. Bondi, C. D. et al. The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice. Eur J Obstet Gynecol Reprod Biol. 174, 80-85 (2014).
54. Mehta, N. R. et al. L-BLP25 Vaccine plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-Expressing Mammary Tumors in Mice. Clin Cancer Res. 18, 2861-2871 (2012).
55. Garnier, P., Ying, W., Swanson, R. A. Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. J Neurosci. 23, 7967-7973 (2003).
56. Quast, S. A., Berger, A., Eberle, J. ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAILinduced apoptosis. Cell Death Dis. 4, e839 (2013).
57. Tarassishin, L., Loudig, O., Bauman, A., Shafit-Zagardo, B., Suh, H. S., Lee, S. C. Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155. Glia. 59, 1911-1922 (2011).